

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glycine metabolic process (GO:0006544) | 5.07595696 |
| 2 | folic acid metabolic process (GO:0046655) | 4.90927895 |
| 3 | serine family amino acid biosynthetic process (GO:0009070) | 4.66962890 |
| 4 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.64638569 |
| 5 | serine family amino acid catabolic process (GO:0009071) | 4.56926639 |
| 6 | sulfur amino acid catabolic process (GO:0000098) | 4.44655654 |
| 7 | L-serine metabolic process (GO:0006563) | 4.39709526 |
| 8 | glycosphingolipid catabolic process (GO:0046479) | 4.31150458 |
| 9 | serine family amino acid metabolic process (GO:0009069) | 4.28304348 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 4.19756753 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.19756753 |
| 12 | glycolipid catabolic process (GO:0019377) | 4.05116767 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.95896572 |
| 14 | GDP-mannose metabolic process (GO:0019673) | 3.92481628 |
| 15 | cysteine metabolic process (GO:0006534) | 3.85641811 |
| 16 | amyloid precursor protein catabolic process (GO:0042987) | 3.84391221 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.83200984 |
| 18 | L-phenylalanine catabolic process (GO:0006559) | 3.83200984 |
| 19 | Golgi transport vesicle coating (GO:0048200) | 3.76838768 |
| 20 | COPI coating of Golgi vesicle (GO:0048205) | 3.76838768 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 3.76648504 |
| 22 | glyoxylate metabolic process (GO:0046487) | 3.68944747 |
| 23 | DNA deamination (GO:0045006) | 3.61156951 |
| 24 | purine nucleobase biosynthetic process (GO:0009113) | 3.60634911 |
| 25 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.57427121 |
| 26 | protein maturation by protein folding (GO:0022417) | 3.53505718 |
| 27 | nucleobase biosynthetic process (GO:0046112) | 3.52509376 |
| 28 | aromatic amino acid family catabolic process (GO:0009074) | 3.50987154 |
| 29 | protein retention in ER lumen (GO:0006621) | 3.45970294 |
| 30 | folic acid transport (GO:0015884) | 3.45455980 |
| 31 | amino-acid betaine metabolic process (GO:0006577) | 3.44245021 |
| 32 | NIK/NF-kappaB signaling (GO:0038061) | 3.41027690 |
| 33 | kynurenine metabolic process (GO:0070189) | 3.40944900 |
| 34 | negative regulation of cholesterol transport (GO:0032375) | 3.35314318 |
| 35 | negative regulation of sterol transport (GO:0032372) | 3.35314318 |
| 36 | folic acid-containing compound metabolic process (GO:0006760) | 3.34520411 |
| 37 | ribosome assembly (GO:0042255) | 3.34336406 |
| 38 | ceramide catabolic process (GO:0046514) | 3.33423832 |
| 39 | sulfur amino acid biosynthetic process (GO:0000097) | 3.30807702 |
| 40 | indole-containing compound catabolic process (GO:0042436) | 3.29217659 |
| 41 | indolalkylamine catabolic process (GO:0046218) | 3.29217659 |
| 42 | tryptophan catabolic process (GO:0006569) | 3.29217659 |
| 43 | barbed-end actin filament capping (GO:0051016) | 3.27419622 |
| 44 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.21524371 |
| 45 | homocysteine metabolic process (GO:0050667) | 3.20424122 |
| 46 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.19950156 |
| 47 | urea cycle (GO:0000050) | 3.19185488 |
| 48 | urea metabolic process (GO:0019627) | 3.19185488 |
| 49 | pentose-phosphate shunt (GO:0006098) | 3.17873468 |
| 50 | pentose metabolic process (GO:0019321) | 3.13955598 |
| 51 | negative regulation of fibrinolysis (GO:0051918) | 3.13539173 |
| 52 | UV protection (GO:0009650) | 3.13162798 |
| 53 | high-density lipoprotein particle remodeling (GO:0034375) | 3.12064843 |
| 54 | pinocytosis (GO:0006907) | 3.11172846 |
| 55 | sphingolipid catabolic process (GO:0030149) | 3.10985005 |
| 56 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.10491477 |
| 57 | nitrogen cycle metabolic process (GO:0071941) | 3.10236120 |
| 58 | nucleoside salvage (GO:0043174) | 3.10003429 |
| 59 | tetrahydrofolate metabolic process (GO:0046653) | 3.09815038 |
| 60 | imidazole-containing compound metabolic process (GO:0052803) | 3.08825444 |
| 61 | membrane lipid catabolic process (GO:0046466) | 3.08564100 |
| 62 | formation of translation preinitiation complex (GO:0001731) | 3.07707530 |
| 63 | alpha-amino acid catabolic process (GO:1901606) | 3.07657446 |
| 64 | bile acid biosynthetic process (GO:0006699) | 3.06553497 |
| 65 | pantothenate metabolic process (GO:0015939) | 3.04183167 |
| 66 | heme transport (GO:0015886) | 3.02134629 |
| 67 | NADPH regeneration (GO:0006740) | 3.02050864 |
| 68 | tryptophan metabolic process (GO:0006568) | 3.00450070 |
| 69 | cellular amino acid catabolic process (GO:0009063) | 2.99518991 |
| 70 | regulation of cholesterol esterification (GO:0010872) | 2.97973142 |
| 71 | cellular modified amino acid catabolic process (GO:0042219) | 2.97615081 |
| 72 | L-methionine salvage (GO:0071267) | 2.96818542 |
| 73 | L-methionine biosynthetic process (GO:0071265) | 2.96818542 |
| 74 | amino acid salvage (GO:0043102) | 2.96818542 |
| 75 | glucose catabolic process (GO:0006007) | 2.95021082 |
| 76 | aromatic amino acid family metabolic process (GO:0009072) | 2.94922971 |
| 77 | sulfur amino acid metabolic process (GO:0000096) | 2.93795352 |
| 78 | lysine catabolic process (GO:0006554) | 2.93058509 |
| 79 | lysine metabolic process (GO:0006553) | 2.93058509 |
| 80 | one-carbon metabolic process (GO:0006730) | 2.91700915 |
| 81 | pteridine-containing compound metabolic process (GO:0042558) | 2.91024121 |
| 82 | regulation of protein activation cascade (GO:2000257) | 2.90817762 |
| 83 | ethanol oxidation (GO:0006069) | 2.90209816 |
| 84 | pyrimidine nucleoside salvage (GO:0043097) | 2.89788629 |
| 85 | pyrimidine-containing compound salvage (GO:0008655) | 2.89788629 |
| 86 | regulation of triglyceride catabolic process (GO:0010896) | 2.88895307 |
| 87 | protein localization to endosome (GO:0036010) | 2.88780557 |
| 88 | proteasome assembly (GO:0043248) | 2.88130618 |
| 89 | oligosaccharide catabolic process (GO:0009313) | 2.85465083 |
| 90 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.85458915 |
| 91 | fructose metabolic process (GO:0006000) | 2.84009403 |
| 92 | valine metabolic process (GO:0006573) | 2.83937970 |
| 93 | proline metabolic process (GO:0006560) | 2.83407926 |
| 94 | reverse cholesterol transport (GO:0043691) | 2.82256076 |
| 95 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.82016633 |
| 96 | ribosome biogenesis (GO:0042254) | 2.81994075 |
| 97 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.81674842 |
| 98 | bile acid metabolic process (GO:0008206) | 2.80113321 |
| 99 | ribosomal small subunit biogenesis (GO:0042274) | 2.79632821 |
| 100 | hyaluronan catabolic process (GO:0030214) | 2.79110812 |
| 101 | plasma lipoprotein particle clearance (GO:0034381) | 2.78913513 |
| 102 | regulation of vitamin metabolic process (GO:0030656) | 2.78906026 |
| 103 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.78337279 |
| 104 | biotin metabolic process (GO:0006768) | 2.77392734 |
| 105 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.76384730 |
| 106 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.76384730 |
| 107 | branched-chain amino acid catabolic process (GO:0009083) | 2.76063904 |
| 108 | regulation of complement activation (GO:0030449) | 2.75788656 |
| 109 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.75538251 |
| 110 | triglyceride homeostasis (GO:0070328) | 2.74511333 |
| 111 | acylglycerol homeostasis (GO:0055090) | 2.74511333 |
| 112 | methionine metabolic process (GO:0006555) | 2.73461267 |
| 113 | plasma lipoprotein particle remodeling (GO:0034369) | 2.72532038 |
| 114 | protein-lipid complex remodeling (GO:0034368) | 2.72532038 |
| 115 | macromolecular complex remodeling (GO:0034367) | 2.72532038 |
| 116 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.70773012 |
| 117 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.69410596 |
| 118 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.69103030 |
| 119 | acetyl-CoA metabolic process (GO:0006084) | 2.67980203 |
| 120 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.67171905 |
| 121 | alpha-amino acid biosynthetic process (GO:1901607) | 2.67082062 |
| 122 | methionine biosynthetic process (GO:0009086) | 2.66917024 |
| 123 | regulation of cholesterol homeostasis (GO:2000188) | 2.66810151 |
| 124 | proline biosynthetic process (GO:0006561) | 2.65586369 |
| 125 | maturation of SSU-rRNA (GO:0030490) | 2.65428309 |
| 126 | amino sugar catabolic process (GO:0046348) | 2.65256790 |
| 127 | organic acid catabolic process (GO:0016054) | 2.64442698 |
| 128 | carboxylic acid catabolic process (GO:0046395) | 2.64442698 |
| 129 | low-density lipoprotein particle clearance (GO:0034383) | 2.61818262 |
| 130 | adhesion of symbiont to host (GO:0044406) | 2.60728771 |
| 131 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.59701395 |
| 132 | virion attachment to host cell (GO:0019062) | 2.58682279 |
| 133 | adhesion of symbiont to host cell (GO:0044650) | 2.58682279 |
| 134 | regulation of superoxide anion generation (GO:0032928) | 2.57705857 |
| 135 | regulation of podosome assembly (GO:0071801) | 2.56735954 |
| 136 | response to peptidoglycan (GO:0032494) | 2.46532709 |
| 137 | response to thyroid hormone (GO:0097066) | 2.45208680 |
| 138 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.45147045 |
| 139 | myeloid cell homeostasis (GO:0002262) | 2.44169414 |
| 140 | cyclooxygenase pathway (GO:0019371) | 2.43188289 |
| 141 | cellular response to arsenic-containing substance (GO:0071243) | 2.42904049 |
| 142 | glucose 6-phosphate metabolic process (GO:0051156) | 2.39209175 |
| 143 | mannose metabolic process (GO:0006013) | 2.39055993 |
| 144 | modulation by symbiont of host cellular process (GO:0044068) | 2.38810257 |
| 145 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.38227202 |
| 146 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.38197446 |
| 147 | heme metabolic process (GO:0042168) | 2.35726609 |
| 148 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.35684177 |
| 149 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.35108347 |
| 150 | glycoside metabolic process (GO:0016137) | 2.34993453 |
| 151 | regulation of cholesterol storage (GO:0010885) | 2.32658821 |
| 152 | virion assembly (GO:0019068) | 2.32463727 |
| 153 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.31612048 |
| 154 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.30953778 |
| 155 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.30274879 |
| 156 | positive regulation of receptor biosynthetic process (GO:0010870) | 2.29018510 |
| 157 | monosaccharide biosynthetic process (GO:0046364) | 2.28310632 |
| 158 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.28026677 |
| 159 | heme biosynthetic process (GO:0006783) | 2.27133380 |
| 160 | mitotic nuclear envelope reassembly (GO:0007084) | 2.27042718 |
| 161 | nuclear envelope reassembly (GO:0031468) | 2.27042718 |
| 162 | regulation of mononuclear cell migration (GO:0071675) | 2.27039554 |
| 163 | mitochondrial fusion (GO:0008053) | 2.26738147 |
| 164 | glial cell migration (GO:0008347) | 2.25016583 |
| 165 | regulation of chemokine biosynthetic process (GO:0045073) | 2.24963474 |
| 166 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.24557951 |
| 167 | positive regulation of T cell apoptotic process (GO:0070234) | 2.23608591 |
| 168 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.21378017 |
| 169 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.21263498 |
| 170 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.20637777 |
| 171 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.20245118 |
| 172 | leukocyte apoptotic process (GO:0071887) | 2.19031869 |
| 173 | T cell apoptotic process (GO:0070231) | 2.18692822 |
| 174 | NADH metabolic process (GO:0006734) | 2.18171828 |
| 175 | N-acetylneuraminate metabolic process (GO:0006054) | 2.17719777 |
| 176 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.16717829 |
| 177 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.15805491 |
| 178 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.15776666 |
| 179 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.15736782 |
| 180 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.14772896 |
| 181 | UTP biosynthetic process (GO:0006228) | 2.13514332 |
| 182 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.13485137 |
| 183 | regulation of mitochondrial membrane potential (GO:0051881) | 2.12754589 |
| 184 | decidualization (GO:0046697) | 2.12558636 |
| 185 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.12170970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.20776180 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.20214030 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.36621131 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.35871710 |
| 5 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.00140391 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.87022998 |
| 7 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.77253509 |
| 8 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.54625384 |
| 9 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.54039360 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.53366961 |
| 11 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.49121594 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.42448624 |
| 13 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.39370699 |
| 14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.35246313 |
| 15 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.27546070 |
| 16 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.25587574 |
| 17 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.24410116 |
| 18 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.19268144 |
| 19 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.17872044 |
| 20 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.17673409 |
| 21 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.05157194 |
| 22 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.98939095 |
| 23 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.97928444 |
| 24 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.97808019 |
| 25 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.95850935 |
| 26 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.95015143 |
| 27 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.92079955 |
| 28 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.90474865 |
| 29 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.83327966 |
| 30 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.79908716 |
| 31 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.78952099 |
| 32 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.78741679 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.73691052 |
| 34 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.69102072 |
| 35 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.68736792 |
| 36 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.68672530 |
| 37 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.64638012 |
| 38 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.64391286 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.59363847 |
| 40 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.58014758 |
| 41 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.57818575 |
| 42 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.55487529 |
| 43 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.54405018 |
| 44 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.53091393 |
| 45 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.52911885 |
| 46 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.51662065 |
| 47 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.50753281 |
| 48 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.49898259 |
| 49 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.49500049 |
| 50 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.45575537 |
| 51 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.44944422 |
| 52 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.44913897 |
| 53 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.44741255 |
| 54 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.42530891 |
| 55 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.42427058 |
| 56 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.42384828 |
| 57 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.39021615 |
| 58 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.37901059 |
| 59 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.37822871 |
| 60 | P68_20966046_ChIP-Seq_HELA_Human | 1.37594931 |
| 61 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.37475174 |
| 62 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.37140903 |
| 63 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34804125 |
| 64 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.34642502 |
| 65 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.34620728 |
| 66 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.34620728 |
| 67 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.34620728 |
| 68 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.33418434 |
| 69 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.31284930 |
| 70 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.30721927 |
| 71 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.30569428 |
| 72 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30265841 |
| 73 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.29718647 |
| 74 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.28169593 |
| 75 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.28100460 |
| 76 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26198030 |
| 77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.25908140 |
| 78 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.25754147 |
| 79 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.24786646 |
| 80 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.24605048 |
| 81 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24601404 |
| 82 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.24357802 |
| 83 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.24153466 |
| 84 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.23983028 |
| 85 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.23720383 |
| 86 | MYC_22102868_ChIP-Seq_BL_Human | 1.21801514 |
| 87 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.21247106 |
| 88 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.20635144 |
| 89 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.20004032 |
| 90 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.19633108 |
| 91 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.19586461 |
| 92 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.18931966 |
| 93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18784046 |
| 94 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.16900232 |
| 95 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.16129616 |
| 96 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.15890380 |
| 97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15837734 |
| 98 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.15508782 |
| 99 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.14732162 |
| 100 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.14646488 |
| 101 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.13166902 |
| 102 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.12028459 |
| 103 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11457187 |
| 104 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.10278474 |
| 105 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.10097915 |
| 106 | MAF_26560356_Chip-Seq_TH1_Human | 1.09340518 |
| 107 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.08784527 |
| 108 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.08527682 |
| 109 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07793122 |
| 110 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.07356210 |
| 111 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.07228345 |
| 112 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.06584349 |
| 113 | MAF_26560356_Chip-Seq_TH2_Human | 1.06567230 |
| 114 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.06263412 |
| 115 | ATF3_27146783_Chip-Seq_COLON_Human | 1.06077368 |
| 116 | * KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.05651821 |
| 117 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05596532 |
| 118 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.05360357 |
| 119 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.05111414 |
| 120 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04793515 |
| 121 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.03651252 |
| 122 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.02807093 |
| 123 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02654200 |
| 124 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02168118 |
| 125 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01948457 |
| 126 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01928911 |
| 127 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.01634089 |
| 128 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01215197 |
| 129 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.00834180 |
| 130 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.00302474 |
| 131 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.98728822 |
| 132 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.98308938 |
| 133 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.98305570 |
| 134 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.97231559 |
| 135 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.95989969 |
| 136 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95653052 |
| 137 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.94966865 |
| 138 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.94349392 |
| 139 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94145359 |
| 140 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.92898847 |
| 141 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.92206692 |
| 142 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.91949703 |
| 143 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.91340637 |
| 144 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.91009871 |
| 145 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89287247 |
| 146 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.89122970 |
| 147 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.87141252 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.32513731 |
| 2 | MP0005360_urolithiasis | 5.06812372 |
| 3 | MP0009840_abnormal_foam_cell | 4.65861744 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 4.63324037 |
| 5 | MP0005365_abnormal_bile_salt | 4.11840581 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.98484473 |
| 7 | MP0004858_abnormal_nervous_system | 3.65546720 |
| 8 | MP0003693_abnormal_embryo_hatching | 3.51101304 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 3.15254887 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.76047896 |
| 11 | MP0004957_abnormal_blastocyst_morpholog | 2.61084174 |
| 12 | MP0005332_abnormal_amino_acid | 2.57445607 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.41879219 |
| 14 | MP0003436_decreased_susceptibility_to | 2.40802192 |
| 15 | MP0003111_abnormal_nucleus_morphology | 2.36133042 |
| 16 | MP0003075_altered_response_to | 2.33007737 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.32719818 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.19703181 |
| 19 | MP0003303_peritoneal_inflammation | 2.15723693 |
| 20 | MP0003186_abnormal_redox_activity | 2.06797990 |
| 21 | MP0001666_abnormal_nutrient_absorption | 2.04434260 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.03574781 |
| 23 | MP0000343_altered_response_to | 1.93551802 |
| 24 | MP0000609_abnormal_liver_physiology | 1.93489836 |
| 25 | MP0003718_maternal_effect | 1.89752109 |
| 26 | MP0006082_CNS_inflammation | 1.89529705 |
| 27 | MP0005083_abnormal_biliary_tract | 1.89494373 |
| 28 | MP0005670_abnormal_white_adipose | 1.77865890 |
| 29 | MP0002877_abnormal_melanocyte_morpholog | 1.77411558 |
| 30 | MP0003252_abnormal_bile_duct | 1.77149140 |
| 31 | MP0009785_altered_susceptibility_to | 1.76027941 |
| 32 | MP0001849_ear_inflammation | 1.74864165 |
| 33 | MP0003077_abnormal_cell_cycle | 1.67330124 |
| 34 | MP0003011_delayed_dark_adaptation | 1.66783234 |
| 35 | MP0003705_abnormal_hypodermis_morpholog | 1.66777445 |
| 36 | MP0005319_abnormal_enzyme/_coenzyme | 1.66695310 |
| 37 | MP0005025_abnormal_response_to | 1.60487196 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.57947429 |
| 39 | MP0002118_abnormal_lipid_homeostasis | 1.57904222 |
| 40 | MP0002419_abnormal_innate_immunity | 1.55268257 |
| 41 | MP0010094_abnormal_chromosome_stability | 1.51033918 |
| 42 | MP0001764_abnormal_homeostasis | 1.46385752 |
| 43 | MP0009764_decreased_sensitivity_to | 1.45385756 |
| 44 | MP0009643_abnormal_urine_homeostasis | 1.42206447 |
| 45 | MP0003453_abnormal_keratinocyte_physiol | 1.41738486 |
| 46 | MP0001835_abnormal_antigen_presentation | 1.41506479 |
| 47 | MP0008932_abnormal_embryonic_tissue | 1.41088560 |
| 48 | MP0005257_abnormal_intraocular_pressure | 1.40152242 |
| 49 | MP0004947_skin_inflammation | 1.39563444 |
| 50 | MP0010352_gastrointestinal_tract_polyps | 1.33999653 |
| 51 | MP0001730_embryonic_growth_arrest | 1.32578839 |
| 52 | MP0010155_abnormal_intestine_physiology | 1.32231600 |
| 53 | MP0003329_amyloid_beta_deposits | 1.32105235 |
| 54 | MP0005387_immune_system_phenotype | 1.29678224 |
| 55 | MP0001790_abnormal_immune_system | 1.29678224 |
| 56 | MP0005000_abnormal_immune_tolerance | 1.28602625 |
| 57 | MP0006035_abnormal_mitochondrial_morpho | 1.26271042 |
| 58 | MP0009278_abnormal_bone_marrow | 1.24059154 |
| 59 | MP0008260_abnormal_autophagy | 1.23885995 |
| 60 | MP0001845_abnormal_inflammatory_respons | 1.23501961 |
| 61 | MP0001533_abnormal_skeleton_physiology | 1.22586525 |
| 62 | MP0004133_heterotaxia | 1.21874592 |
| 63 | MP0000598_abnormal_liver_morphology | 1.18831921 |
| 64 | MP0008058_abnormal_DNA_repair | 1.18667062 |
| 65 | MP0006036_abnormal_mitochondrial_physio | 1.18430462 |
| 66 | MP0002254_reproductive_system_inflammat | 1.16988937 |
| 67 | MP0000685_abnormal_immune_system | 1.15730799 |
| 68 | MP0005464_abnormal_platelet_physiology | 1.13637690 |
| 69 | MP0003195_calcinosis | 1.13333004 |
| 70 | MP0005165_increased_susceptibility_to | 1.12619760 |
| 71 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.12519366 |
| 72 | MP0002452_abnormal_antigen_presenting | 1.10619007 |
| 73 | MP0002653_abnormal_ependyma_morphology | 1.07956197 |
| 74 | MP0005671_abnormal_response_to | 1.07417324 |
| 75 | MP0005451_abnormal_body_composition | 1.06605641 |
| 76 | MP0005058_abnormal_lysosome_morphology | 1.06164346 |
| 77 | MP0000490_abnormal_crypts_of | 1.04611828 |
| 78 | MP0005166_decreased_susceptibility_to | 1.03714527 |
| 79 | MP0002723_abnormal_immune_serum | 1.03612339 |
| 80 | MP0001727_abnormal_embryo_implantation | 1.03484250 |
| 81 | MP0000350_abnormal_cell_proliferation | 0.99808749 |
| 82 | MP0001756_abnormal_urination | 0.98711316 |
| 83 | MP0003448_altered_tumor_morphology | 0.96654188 |
| 84 | MP0004233_abnormal_muscle_weight | 0.95840944 |
| 85 | MP0005380_embryogenesis_phenotype | 0.94508587 |
| 86 | MP0001672_abnormal_embryogenesis/_devel | 0.94508587 |
| 87 | MP0001661_extended_life_span | 0.94267330 |
| 88 | MP0000358_abnormal_cell_content/ | 0.94217561 |
| 89 | MP0001853_heart_inflammation | 0.93438114 |
| 90 | MP0004264_abnormal_extraembryonic_tissu | 0.92261867 |
| 91 | MP0002080_prenatal_lethality | 0.91893494 |
| 92 | MP0001819_abnormal_immune_cell | 0.91579852 |
| 93 | MP0002132_abnormal_respiratory_system | 0.90618604 |
| 94 | MP0002420_abnormal_adaptive_immunity | 0.89376415 |
| 95 | MP0002138_abnormal_hepatobiliary_system | 0.88243625 |
| 96 | MP0002998_abnormal_bone_remodeling | 0.87335099 |
| 97 | MP0005666_abnormal_adipose_tissue | 0.85871836 |
| 98 | MP0002405_respiratory_system_inflammati | 0.84889814 |
| 99 | MP0009333_abnormal_splenocyte_physiolog | 0.83707584 |
| 100 | MP0010030_abnormal_orbit_morphology | 0.82788819 |
| 101 | MP0002019_abnormal_tumor_incidence | 0.82602706 |
| 102 | MP0005266_abnormal_metabolism | 0.82068689 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.81890734 |
| 104 | MP0010234_abnormal_vibrissa_follicle | 0.80987277 |
| 105 | MP0001697_abnormal_embryo_size | 0.80327908 |
| 106 | MP0001545_abnormal_hematopoietic_system | 0.80020004 |
| 107 | MP0005397_hematopoietic_system_phenotyp | 0.80020004 |
| 108 | MP0002088_abnormal_embryonic_growth/wei | 0.79703681 |
| 109 | MP0003984_embryonic_growth_retardation | 0.79666711 |
| 110 | MP0001663_abnormal_digestive_system | 0.79413605 |
| 111 | MP0001873_stomach_inflammation | 0.78526107 |
| 112 | MP0005395_other_phenotype | 0.78345819 |
| 113 | MP0004510_myositis | 0.78237378 |
| 114 | MP0001881_abnormal_mammary_gland | 0.77928549 |
| 115 | MP0008469_abnormal_protein_level | 0.77102161 |
| 116 | MP0010307_abnormal_tumor_latency | 0.76726551 |
| 117 | MP0008004_abnormal_stomach_pH | 0.76681866 |
| 118 | MP0002136_abnormal_kidney_physiology | 0.76361201 |
| 119 | MP0008007_abnormal_cellular_replicative | 0.76145079 |
| 120 | MP0002429_abnormal_blood_cell | 0.74323457 |
| 121 | MP0003868_abnormal_feces_composition | 0.74214489 |
| 122 | MP0003786_premature_aging | 0.73887681 |
| 123 | MP0002086_abnormal_extraembryonic_tissu | 0.72585363 |
| 124 | MP0001800_abnormal_humoral_immune | 0.72525533 |
| 125 | MP0003890_abnormal_embryonic-extraembry | 0.72044918 |
| 126 | MP0000678_abnormal_parathyroid_gland | 0.71812099 |
| 127 | MP0009053_abnormal_anal_canal | 0.70343640 |
| 128 | MP0000477_abnormal_intestine_morphology | 0.70258891 |
| 129 | MP0002796_impaired_skin_barrier | 0.70134940 |
| 130 | MP0005376_homeostasis/metabolism_phenot | 0.69485390 |
| 131 | MP0003566_abnormal_cell_adhesion | 0.69277259 |
| 132 | MP0002970_abnormal_white_adipose | 0.69105665 |
| 133 | MP0003119_abnormal_digestive_system | 0.68953345 |
| 134 | MP0005023_abnormal_wound_healing | 0.68852040 |
| 135 | MP0001216_abnormal_epidermal_layer | 0.68663791 |
| 136 | MP0009763_increased_sensitivity_to | 0.68574852 |
| 137 | MP0001243_abnormal_dermal_layer | 0.68459426 |
| 138 | MP0000604_amyloidosis | 0.68444904 |
| 139 | MP0005377_hearing/vestibular/ear_phenot | 0.67994411 |
| 140 | MP0003878_abnormal_ear_physiology | 0.67994411 |
| 141 | MP0001542_abnormal_bone_strength | 0.67509365 |
| 142 | MP0004782_abnormal_surfactant_physiolog | 0.67435887 |
| 143 | MP0002085_abnormal_embryonic_tissue | 0.67391769 |
| 144 | MP0009642_abnormal_blood_homeostasis | 0.67323718 |
| 145 | MP0005636_abnormal_mineral_homeostasis | 0.67115566 |
| 146 | MP0000858_altered_metastatic_potential | 0.66060686 |
| 147 | MP0009672_abnormal_birth_weight | 0.64464276 |
| 148 | MP0009765_abnormal_xenobiotic_induced | 0.62421987 |
| 149 | MP0000313_abnormal_cell_death | 0.61729549 |
| 150 | MP0004197_abnormal_fetal_growth/weight/ | 0.59538439 |
| 151 | MP0005501_abnormal_skin_physiology | 0.57851665 |
| 152 | MP0003221_abnormal_cardiomyocyte_apopto | 0.57628469 |
| 153 | MP0002084_abnormal_developmental_patter | 0.55594839 |
| 154 | MP0005647_abnormal_sex_gland | 0.55578040 |
| 155 | MP0002111_abnormal_tail_morphology | 0.53956618 |
| 156 | MP0001293_anophthalmia | 0.53579981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 5.71038164 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.71038164 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.71038164 |
| 4 | Hyperglycinuria (HP:0003108) | 5.49066468 |
| 5 | Hyperglycinemia (HP:0002154) | 5.13721105 |
| 6 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.90737720 |
| 7 | Abnormality of glycine metabolism (HP:0010895) | 4.90737720 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.77638065 |
| 9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.54509852 |
| 10 | Increased cerebral lipofuscin (HP:0011813) | 4.38778260 |
| 11 | Xanthomatosis (HP:0000991) | 4.34538660 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 4.27544628 |
| 13 | Hyperammonemia (HP:0001987) | 4.21129786 |
| 14 | Intrahepatic cholestasis (HP:0001406) | 4.14086280 |
| 15 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.99759630 |
| 16 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.96178719 |
| 17 | Vacuolated lymphocytes (HP:0001922) | 3.94177951 |
| 18 | Hyperlipoproteinemia (HP:0010980) | 3.86130901 |
| 19 | Vertebral compression fractures (HP:0002953) | 3.77999436 |
| 20 | Deep venous thrombosis (HP:0002625) | 3.70124675 |
| 21 | Dysostosis multiplex (HP:0000943) | 3.67674204 |
| 22 | Multiple enchondromatosis (HP:0005701) | 3.45339440 |
| 23 | Abnormality of serum amino acid levels (HP:0003112) | 3.44706257 |
| 24 | Hypolipoproteinemia (HP:0010981) | 3.40837800 |
| 25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.39774134 |
| 26 | Loss of speech (HP:0002371) | 3.25916519 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.23680368 |
| 28 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.14935061 |
| 29 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.10042409 |
| 30 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.10042409 |
| 31 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.10042409 |
| 32 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.06451754 |
| 33 | Dicarboxylic aciduria (HP:0003215) | 3.06451754 |
| 34 | Hypoalphalipoproteinemia (HP:0003233) | 3.05158434 |
| 35 | Breast hypoplasia (HP:0003187) | 3.02782034 |
| 36 | Oral leukoplakia (HP:0002745) | 3.00222226 |
| 37 | Lethargy (HP:0001254) | 2.93159725 |
| 38 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.91490743 |
| 39 | Mucopolysacchariduria (HP:0008155) | 2.90738929 |
| 40 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.90738929 |
| 41 | Gout (HP:0001997) | 2.89816773 |
| 42 | Ketosis (HP:0001946) | 2.87905009 |
| 43 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.86925257 |
| 44 | Prolonged partial thromboplastin time (HP:0003645) | 2.86001572 |
| 45 | Complement deficiency (HP:0004431) | 2.82666372 |
| 46 | Abnormality of nucleobase metabolism (HP:0010932) | 2.80785942 |
| 47 | Abnormality of methionine metabolism (HP:0010901) | 2.80395892 |
| 48 | Spastic diplegia (HP:0001264) | 2.76395059 |
| 49 | Megaloblastic anemia (HP:0001889) | 2.73212585 |
| 50 | Delayed CNS myelination (HP:0002188) | 2.69115469 |
| 51 | Hypoglycemic coma (HP:0001325) | 2.65684445 |
| 52 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.65057822 |
| 53 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.65032775 |
| 54 | Abnormality of macrophages (HP:0004311) | 2.64807687 |
| 55 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.62148685 |
| 56 | Nausea (HP:0002018) | 2.62040861 |
| 57 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.53180102 |
| 58 | Abnormal cartilage morphology (HP:0002763) | 2.50746495 |
| 59 | Purpura (HP:0000979) | 2.46072229 |
| 60 | Reticulocytopenia (HP:0001896) | 2.44735026 |
| 61 | Axonal loss (HP:0003447) | 2.41307190 |
| 62 | Thoracic kyphosis (HP:0002942) | 2.40931357 |
| 63 | Progressive neurologic deterioration (HP:0002344) | 2.34101828 |
| 64 | Upper motor neuron abnormality (HP:0002127) | 2.34045349 |
| 65 | Abnormal gallbladder physiology (HP:0012438) | 2.31949159 |
| 66 | Cholecystitis (HP:0001082) | 2.31949159 |
| 67 | Irritability (HP:0000737) | 2.31745373 |
| 68 | Nuclear cataract (HP:0100018) | 2.31263609 |
| 69 | Malnutrition (HP:0004395) | 2.29365467 |
| 70 | Impulsivity (HP:0100710) | 2.28711456 |
| 71 | Ragged-red muscle fibers (HP:0003200) | 2.28493158 |
| 72 | Abnormality of complement system (HP:0005339) | 2.26691702 |
| 73 | Abnormal trabecular bone morphology (HP:0100671) | 2.26479188 |
| 74 | Achilles tendon contracture (HP:0001771) | 2.24545999 |
| 75 | Epidermoid cyst (HP:0200040) | 2.22851109 |
| 76 | Rough bone trabeculation (HP:0100670) | 2.22209271 |
| 77 | Birth length less than 3rd percentile (HP:0003561) | 2.21923890 |
| 78 | Abnormality of purine metabolism (HP:0004352) | 2.21299098 |
| 79 | Fat malabsorption (HP:0002630) | 2.19306536 |
| 80 | Macrocytic anemia (HP:0001972) | 2.18483967 |
| 81 | Progressive muscle weakness (HP:0003323) | 2.18058652 |
| 82 | Opisthotonus (HP:0002179) | 2.17849405 |
| 83 | Hypertensive crisis (HP:0100735) | 2.14218578 |
| 84 | Hemorrhage of the eye (HP:0011885) | 2.14189701 |
| 85 | Recurrent abscess formation (HP:0002722) | 2.12874553 |
| 86 | Chronic obstructive pulmonary disease (HP:0006510) | 2.12118821 |
| 87 | Obstructive lung disease (HP:0006536) | 2.12118821 |
| 88 | Amyloidosis (HP:0011034) | 2.10936851 |
| 89 | Abnormality of the Achilles tendon (HP:0005109) | 2.10572915 |
| 90 | Autoimmune thrombocytopenia (HP:0001973) | 2.10337980 |
| 91 | Spastic paraparesis (HP:0002313) | 2.10124016 |
| 92 | Death in infancy (HP:0001522) | 2.10052200 |
| 93 | Microretrognathia (HP:0000308) | 2.06376005 |
| 94 | Hepatosplenomegaly (HP:0001433) | 2.06351478 |
| 95 | Glomerulonephritis (HP:0000099) | 2.05542763 |
| 96 | Carpal bone hypoplasia (HP:0001498) | 2.04962590 |
| 97 | CNS demyelination (HP:0007305) | 2.04267690 |
| 98 | Abnormality of the thoracic spine (HP:0100711) | 2.01373485 |
| 99 | Cerebral hypomyelination (HP:0006808) | 2.01049598 |
| 100 | Ependymoma (HP:0002888) | 2.00142511 |
| 101 | Recurrent bacterial skin infections (HP:0005406) | 1.99931919 |
| 102 | Hyperacusis (HP:0010780) | 1.99911789 |
| 103 | Joint hemorrhage (HP:0005261) | 1.99848840 |
| 104 | Distal upper limb amyotrophy (HP:0007149) | 1.99072730 |
| 105 | Upper limb amyotrophy (HP:0009129) | 1.99072730 |
| 106 | Vomiting (HP:0002013) | 1.97891027 |
| 107 | Hypercholesterolemia (HP:0003124) | 1.96489006 |
| 108 | Premature ovarian failure (HP:0008209) | 1.95533652 |
| 109 | Polygenic inheritance (HP:0010982) | 1.94545130 |
| 110 | Hyperbilirubinemia (HP:0002904) | 1.93904841 |
| 111 | Elevated alkaline phosphatase (HP:0003155) | 1.93814541 |
| 112 | Neurofibrillary tangles (HP:0002185) | 1.93567655 |
| 113 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.93528284 |
| 114 | Petechiae (HP:0000967) | 1.93328783 |
| 115 | Pseudobulbar signs (HP:0002200) | 1.92494731 |
| 116 | Brushfield spots (HP:0001088) | 1.92188168 |
| 117 | Metabolic acidosis (HP:0001942) | 1.91436541 |
| 118 | Prolonged neonatal jaundice (HP:0006579) | 1.91008900 |
| 119 | Hypokinesia (HP:0002375) | 1.90712978 |
| 120 | Abnormality of the common coagulation pathway (HP:0010990) | 1.90061273 |
| 121 | Hydroxyprolinuria (HP:0003080) | 1.89464513 |
| 122 | Abnormality of proline metabolism (HP:0010907) | 1.89464513 |
| 123 | Esophageal varix (HP:0002040) | 1.88898261 |
| 124 | Abnormality of the intrinsic pathway (HP:0010989) | 1.87275523 |
| 125 | Abnormality of iron homeostasis (HP:0011031) | 1.87009743 |
| 126 | 3-Methylglutaconic aciduria (HP:0003535) | 1.84449293 |
| 127 | Sparse eyelashes (HP:0000653) | 1.84088033 |
| 128 | Interstitial pulmonary disease (HP:0006530) | 1.83268383 |
| 129 | Ketoacidosis (HP:0001993) | 1.83113537 |
| 130 | Trismus (HP:0000211) | 1.82081533 |
| 131 | Generalized aminoaciduria (HP:0002909) | 1.82075264 |
| 132 | Cervical subluxation (HP:0003308) | 1.82048811 |
| 133 | Mediastinal lymphadenopathy (HP:0100721) | 1.81962497 |
| 134 | J-shaped sella turcica (HP:0002680) | 1.81479965 |
| 135 | Long palpebral fissure (HP:0000637) | 1.81236155 |
| 136 | Increased purine levels (HP:0004368) | 1.80522961 |
| 137 | Hyperuricemia (HP:0002149) | 1.80522961 |
| 138 | Cholelithiasis (HP:0001081) | 1.80498299 |
| 139 | Hypertriglyceridemia (HP:0002155) | 1.80256182 |
| 140 | Myocardial infarction (HP:0001658) | 1.80255306 |
| 141 | Pancreatitis (HP:0001733) | 1.80199171 |
| 142 | Reduced antithrombin III activity (HP:0001976) | 1.80049656 |
| 143 | Thin bony cortex (HP:0002753) | 1.79936648 |
| 144 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.79658161 |
| 145 | Reticulocytosis (HP:0001923) | 1.78899557 |
| 146 | Hand muscle atrophy (HP:0009130) | 1.78275579 |
| 147 | Systemic lupus erythematosus (HP:0002725) | 1.78095290 |
| 148 | Late onset (HP:0003584) | 1.77394255 |
| 149 | Cardiomegaly (HP:0001640) | 1.77022465 |
| 150 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.76683480 |
| 151 | Premature rupture of membranes (HP:0001788) | 1.76226339 |
| 152 | Secondary amenorrhea (HP:0000869) | 1.75351860 |
| 153 | Multiple lipomas (HP:0001012) | 1.75267812 |
| 154 | Steatorrhea (HP:0002570) | 1.75236050 |
| 155 | Pathologic fracture (HP:0002756) | 1.74752046 |
| 156 | Cerebral edema (HP:0002181) | 1.74642172 |
| 157 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.74417181 |
| 158 | Neonatal onset (HP:0003623) | 1.74245667 |
| 159 | Cerebral palsy (HP:0100021) | 1.73543722 |
| 160 | Microvesicular hepatic steatosis (HP:0001414) | 1.73542616 |
| 161 | Nonimmune hydrops fetalis (HP:0001790) | 1.73004173 |
| 162 | Bone pain (HP:0002653) | 1.72660547 |
| 163 | Eczematoid dermatitis (HP:0000976) | 1.72257065 |
| 164 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.71958582 |
| 165 | Abnormal protein glycosylation (HP:0012346) | 1.71958582 |
| 166 | Abnormal glycosylation (HP:0012345) | 1.71958582 |
| 167 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.71958582 |
| 168 | Fasciculations (HP:0002380) | 1.71547062 |
| 169 | Ureteral duplication (HP:0000073) | 1.71051291 |
| 170 | Hyperparathyroidism (HP:0000843) | 1.70284431 |
| 171 | Back pain (HP:0003418) | 1.69355378 |
| 172 | Increased serum ferritin (HP:0003281) | 1.68838062 |
| 173 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.68764739 |
| 174 | Proximal tubulopathy (HP:0000114) | 1.68601379 |
| 175 | Personality changes (HP:0000751) | 1.67844530 |
| 176 | Abnormality of the nasal mucosa (HP:0000433) | 1.65796470 |
| 177 | Abnormality of reticulocytes (HP:0004312) | 1.64242102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.98322388 |
| 2 | BCKDK | 4.12740112 |
| 3 | EPHA2 | 3.91631020 |
| 4 | WEE1 | 3.73040745 |
| 5 | SMG1 | 3.05412389 |
| 6 | TESK2 | 2.89877627 |
| 7 | NME2 | 2.79344671 |
| 8 | STK16 | 2.79047611 |
| 9 | VRK2 | 2.61924391 |
| 10 | NEK1 | 2.33963592 |
| 11 | RPS6KB2 | 2.14388068 |
| 12 | ERN1 | 2.11133255 |
| 13 | TTK | 2.09918855 |
| 14 | DYRK3 | 2.02110797 |
| 15 | NEK2 | 2.01712961 |
| 16 | TRIB3 | 1.93896347 |
| 17 | EIF2AK1 | 1.84452818 |
| 18 | TBK1 | 1.76175913 |
| 19 | PRPF4B | 1.73688701 |
| 20 | MAP3K11 | 1.66054741 |
| 21 | RPS6KA4 | 1.49657885 |
| 22 | LIMK1 | 1.48665696 |
| 23 | CDK7 | 1.47731399 |
| 24 | IRAK3 | 1.42597279 |
| 25 | MAP3K8 | 1.42143326 |
| 26 | TSSK6 | 1.41848916 |
| 27 | PLK4 | 1.41196113 |
| 28 | SIK1 | 1.38839220 |
| 29 | PRKD3 | 1.37800349 |
| 30 | PLK1 | 1.35697715 |
| 31 | EIF2AK3 | 1.35352676 |
| 32 | GRK6 | 1.34851913 |
| 33 | AKT3 | 1.34422009 |
| 34 | PAK4 | 1.33756388 |
| 35 | MAP2K2 | 1.30302841 |
| 36 | BLK | 1.27600734 |
| 37 | CDK4 | 1.26488318 |
| 38 | RIPK1 | 1.22139599 |
| 39 | KDR | 1.20881753 |
| 40 | MAP4K1 | 1.19447859 |
| 41 | AURKA | 1.19018792 |
| 42 | PKN2 | 1.16453071 |
| 43 | TLK1 | 1.10780585 |
| 44 | MAPKAPK3 | 1.10617498 |
| 45 | FGFR4 | 1.10556332 |
| 46 | LRRK2 | 1.08325627 |
| 47 | AURKB | 1.08007943 |
| 48 | TESK1 | 1.07147942 |
| 49 | VRK1 | 1.03799917 |
| 50 | PRKCI | 0.99967295 |
| 51 | CDK8 | 0.98904129 |
| 52 | SCYL2 | 0.98362493 |
| 53 | EEF2K | 0.96788431 |
| 54 | LMTK2 | 0.96134371 |
| 55 | IRAK4 | 0.95868926 |
| 56 | DAPK3 | 0.95685232 |
| 57 | TAOK2 | 0.92057665 |
| 58 | PIM2 | 0.91248924 |
| 59 | FLT3 | 0.89913694 |
| 60 | MST1R | 0.88923042 |
| 61 | CDC7 | 0.87092575 |
| 62 | MOS | 0.86340426 |
| 63 | DDR2 | 0.86176342 |
| 64 | ABL2 | 0.85122899 |
| 65 | MAPK11 | 0.84876924 |
| 66 | STK10 | 0.84372947 |
| 67 | SRPK1 | 0.82261256 |
| 68 | MAP3K14 | 0.81577574 |
| 69 | CHEK2 | 0.80496925 |
| 70 | BRAF | 0.78694687 |
| 71 | DYRK2 | 0.76957814 |
| 72 | TAOK1 | 0.76311471 |
| 73 | PAK1 | 0.74477926 |
| 74 | ALK | 0.73306374 |
| 75 | DAPK1 | 0.73153955 |
| 76 | MAP3K1 | 0.72688923 |
| 77 | BRSK1 | 0.72371717 |
| 78 | PRKD2 | 0.70240971 |
| 79 | LATS2 | 0.69688759 |
| 80 | ZAP70 | 0.68412111 |
| 81 | IKBKB | 0.68250971 |
| 82 | PIM1 | 0.68091955 |
| 83 | TYK2 | 0.67369834 |
| 84 | PASK | 0.67362366 |
| 85 | BRSK2 | 0.66116313 |
| 86 | CSNK1G3 | 0.65626352 |
| 87 | ILK | 0.65541214 |
| 88 | ATR | 0.65266565 |
| 89 | PTK6 | 0.64660704 |
| 90 | PBK | 0.64252774 |
| 91 | TGFBR2 | 0.63903766 |
| 92 | RPS6KA2 | 0.60186474 |
| 93 | CHEK1 | 0.59403754 |
| 94 | PINK1 | 0.59110812 |
| 95 | CDK6 | 0.57900518 |
| 96 | ACVR1B | 0.55848044 |
| 97 | ICK | 0.54980331 |
| 98 | MTOR | 0.53777419 |
| 99 | CSNK1A1L | 0.53443765 |
| 100 | EPHB2 | 0.53198262 |
| 101 | PDPK1 | 0.52952556 |
| 102 | CSNK2A1 | 0.52881174 |
| 103 | CSNK2A2 | 0.52562289 |
| 104 | MAP3K3 | 0.52381944 |
| 105 | GRK7 | 0.52155007 |
| 106 | AKT2 | 0.50107224 |
| 107 | MAP3K10 | 0.49122542 |
| 108 | CDC42BPA | 0.48688000 |
| 109 | CDK14 | 0.47875987 |
| 110 | MAP2K3 | 0.46888452 |
| 111 | CLK1 | 0.46727324 |
| 112 | CDK12 | 0.46309281 |
| 113 | MAP3K6 | 0.45902417 |
| 114 | RPS6KL1 | 0.45633869 |
| 115 | RPS6KC1 | 0.45633869 |
| 116 | MAP3K5 | 0.45584691 |
| 117 | PLK3 | 0.44289957 |
| 118 | CDK2 | 0.44008060 |
| 119 | SIK3 | 0.43114997 |
| 120 | CDK11A | 0.42104722 |
| 121 | CSF1R | 0.41706847 |
| 122 | CDK9 | 0.40175658 |
| 123 | CDK15 | 0.40021972 |
| 124 | ERBB4 | 0.39982984 |
| 125 | IRAK2 | 0.39028127 |
| 126 | NME1 | 0.38551947 |
| 127 | BMX | 0.38037330 |
| 128 | DYRK1B | 0.37666016 |
| 129 | PDK3 | 0.36056517 |
| 130 | PDK4 | 0.36056517 |
| 131 | CCNB1 | 0.34949647 |
| 132 | STK38L | 0.34159086 |
| 133 | CDK18 | 0.33990900 |
| 134 | MAP2K7 | 0.32608157 |
| 135 | CSNK1E | 0.32027329 |
| 136 | MATK | 0.29707063 |
| 137 | EIF2AK2 | 0.29582514 |
| 138 | MAP2K6 | 0.26691399 |
| 139 | IRAK1 | 0.25667373 |
| 140 | MAPK4 | 0.24002621 |
| 141 | ERBB2 | 0.23901124 |
| 142 | PRKG2 | 0.22269145 |
| 143 | PDK2 | 0.21541767 |
| 144 | ARAF | 0.21392166 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.91327842 |
| 2 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.66319321 |
| 3 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.64642979 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.57110875 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.33490787 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.23091415 |
| 7 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.17332668 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.08623442 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 2.08147409 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.06284843 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.05367473 |
| 12 | Sulfur relay system_Homo sapiens_hsa04122 | 2.04474931 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.04403076 |
| 14 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.03542185 |
| 15 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.03499334 |
| 16 | DNA replication_Homo sapiens_hsa03030 | 2.01972852 |
| 17 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.99477936 |
| 18 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.97216525 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.93872986 |
| 20 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.86618294 |
| 21 | Ribosome_Homo sapiens_hsa03010 | 1.86391594 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.75305768 |
| 23 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.73868935 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.72889794 |
| 25 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.69630951 |
| 26 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.69082814 |
| 27 | Carbon metabolism_Homo sapiens_hsa01200 | 1.66890672 |
| 28 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.66176460 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.63750075 |
| 30 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.62644381 |
| 31 | Mismatch repair_Homo sapiens_hsa03430 | 1.58524611 |
| 32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.58340965 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.55924993 |
| 34 | RNA polymerase_Homo sapiens_hsa03020 | 1.55069681 |
| 35 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.54687120 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.54367546 |
| 37 | Bladder cancer_Homo sapiens_hsa05219 | 1.53026397 |
| 38 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.52146881 |
| 39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.49817082 |
| 40 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.45556796 |
| 41 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.42229768 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.40227296 |
| 43 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.36591010 |
| 44 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.36154889 |
| 45 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.34087213 |
| 46 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.31300857 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.30677344 |
| 48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.28738556 |
| 49 | Base excision repair_Homo sapiens_hsa03410 | 1.25509296 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.23560725 |
| 51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.22742933 |
| 52 | Histidine metabolism_Homo sapiens_hsa00340 | 1.22573699 |
| 53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20678505 |
| 54 | Spliceosome_Homo sapiens_hsa03040 | 1.18475559 |
| 55 | RNA transport_Homo sapiens_hsa03013 | 1.16675824 |
| 56 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.16187164 |
| 57 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.15994873 |
| 58 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.15493678 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.14824963 |
| 60 | Retinol metabolism_Homo sapiens_hsa00830 | 1.14582846 |
| 61 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.12524335 |
| 62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.12509416 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.12481112 |
| 64 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.11313516 |
| 65 | Pertussis_Homo sapiens_hsa05133 | 1.11058928 |
| 66 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.09702871 |
| 67 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.05531089 |
| 68 | Salmonella infection_Homo sapiens_hsa05132 | 1.05028627 |
| 69 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.04619046 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.02433155 |
| 71 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.01882021 |
| 72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.01608061 |
| 73 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.01084986 |
| 74 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.99996328 |
| 75 | Shigellosis_Homo sapiens_hsa05131 | 0.98800736 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.98191270 |
| 77 | Apoptosis_Homo sapiens_hsa04210 | 0.93274913 |
| 78 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.92036145 |
| 79 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.90315991 |
| 80 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.85824557 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.85511933 |
| 82 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.85426617 |
| 83 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.85265383 |
| 84 | Homologous recombination_Homo sapiens_hsa03440 | 0.85034698 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81815684 |
| 86 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.80830000 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.78645296 |
| 88 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.78297785 |
| 89 | Leishmaniasis_Homo sapiens_hsa05140 | 0.77789963 |
| 90 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.77488451 |
| 91 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77349410 |
| 92 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.76335792 |
| 93 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.75745505 |
| 94 | Asthma_Homo sapiens_hsa05310 | 0.75664850 |
| 95 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.72399729 |
| 96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72222903 |
| 97 | Bile secretion_Homo sapiens_hsa04976 | 0.71890369 |
| 98 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.71101794 |
| 99 | Hepatitis C_Homo sapiens_hsa05160 | 0.70054100 |
| 100 | Tuberculosis_Homo sapiens_hsa05152 | 0.68304504 |
| 101 | Metabolic pathways_Homo sapiens_hsa01100 | 0.68028176 |
| 102 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.64558369 |
| 103 | Influenza A_Homo sapiens_hsa05164 | 0.64052092 |
| 104 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.63828153 |
| 105 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63798282 |
| 106 | Legionellosis_Homo sapiens_hsa05134 | 0.59202099 |
| 107 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57092092 |
| 108 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.54151308 |
| 109 | Cell cycle_Homo sapiens_hsa04110 | 0.53437101 |
| 110 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.53233702 |
| 111 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.52766510 |
| 112 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.52118353 |
| 113 | Purine metabolism_Homo sapiens_hsa00230 | 0.51301367 |
| 114 | Mineral absorption_Homo sapiens_hsa04978 | 0.51240866 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51045959 |
| 116 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49872161 |
| 117 | Malaria_Homo sapiens_hsa05144 | 0.49372729 |
| 118 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48842376 |
| 119 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.48571772 |
| 120 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.47703136 |
| 121 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.46975633 |
| 122 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45602985 |
| 123 | Allograft rejection_Homo sapiens_hsa05330 | 0.45230081 |
| 124 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.45113575 |
| 125 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44891588 |
| 126 | Lysine degradation_Homo sapiens_hsa00310 | 0.44738509 |
| 127 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44447627 |
| 128 | ABC transporters_Homo sapiens_hsa02010 | 0.43785430 |
| 129 | Other glycan degradation_Homo sapiens_hsa00511 | 0.38127775 |
| 130 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.36952416 |
| 131 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.34355400 |
| 132 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.34040331 |
| 133 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34034358 |
| 134 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.25559734 |
| 135 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24307228 |
| 136 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.22083764 |
| 137 | Lysosome_Homo sapiens_hsa04142 | 0.21572669 |
| 138 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.20519621 |
| 139 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.16888934 |
| 140 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.15881490 |
| 141 | Prion diseases_Homo sapiens_hsa05020 | 0.10878515 |

